210 related articles for article (PubMed ID: 29871519)
1. Vascular Delivery of Allogeneic MuStem Cells in Dystrophic Dogs Requires Only Short-Term Immunosuppression to Avoid Host Immunity and Generate Clinical/Tissue Benefits.
Lorant J; Larcher T; Jaulin N; Hedan B; Lardenois A; Leroux I; Dubreil L; Ledevin M; Goubin H; Moullec S; Deschamps JY; Thorin C; André C; Adjali O; Rouger K
Cell Transplant; 2018 Jul; 27(7):1096-1110. PubMed ID: 29871519
[TBL] [Abstract][Full Text] [Related]
2. Identification in GRMD dog muscle of critical miRNAs involved in pathophysiology and effects associated with MuStem cell transplantation.
Robriquet F; Babarit C; Larcher T; Dubreil L; Ledevin M; Goubin H; Rouger K; Guével L
BMC Musculoskelet Disord; 2016 May; 17():209. PubMed ID: 27170302
[TBL] [Abstract][Full Text] [Related]
3. Differential Gene Expression Profiling of Dystrophic Dog Muscle after MuStem Cell Transplantation.
Robriquet F; Lardenois A; Babarit C; Larcher T; Dubreil L; Leroux I; Zuber C; Ledevin M; Deschamps JY; Fromes Y; Cherel Y; Guevel L; Rouger K
PLoS One; 2015; 10(5):e0123336. PubMed ID: 25955839
[TBL] [Abstract][Full Text] [Related]
4. Early transplantation of human immature dental pulp stem cells from baby teeth to golden retriever muscular dystrophy (GRMD) dogs: Local or systemic?
Kerkis I; Ambrosio CE; Kerkis A; Martins DS; Zucconi E; Fonseca SA; Cabral RM; Maranduba CM; Gaiad TP; Morini AC; Vieira NM; Brolio MP; Sant'Anna OA; Miglino MA; Zatz M
J Transl Med; 2008 Jul; 6():35. PubMed ID: 18598348
[TBL] [Abstract][Full Text] [Related]
5. Quantitative proteome profiling of dystrophic dog skeletal muscle reveals a stabilized muscular architecture and protection against oxidative stress after systemic delivery of MuStem cells.
Lardenois A; Jagot S; Lagarrigue M; Guével B; Ledevin M; Larcher T; Dubreil L; Pineau C; Rouger K; Guével L
Proteomics; 2016 Jul; 16(14):2028-42. PubMed ID: 27246553
[TBL] [Abstract][Full Text] [Related]
6. Systemic delivery of allogenic muscle stem cells induces long-term muscle repair and clinical efficacy in duchenne muscular dystrophy dogs.
Rouger K; Larcher T; Dubreil L; Deschamps JY; Le Guiner C; Jouvion G; Delorme B; Lieubeau B; Carlus M; Fornasari B; Theret M; Orlando P; Ledevin M; Zuber C; Leroux I; Deleau S; Guigand L; Testault I; Le Rumeur E; Fiszman M; Chérel Y
Am J Pathol; 2011 Nov; 179(5):2501-18. PubMed ID: 21924229
[TBL] [Abstract][Full Text] [Related]
7. Adaptive Immune Response Impairs the Efficacy of Autologous Transplantation of Engineered Stem Cells in Dystrophic Dogs.
Sitzia C; Farini A; Jardim L; Razini P; Belicchi M; Cassinelli L; Villa C; Erratico S; Parolini D; Bella P; da Silva Bizario JC; Garcia L; Dias-Baruffi M; Meregalli M; Torrente Y
Mol Ther; 2016 Nov; 24(11):1949-1964. PubMed ID: 27506452
[TBL] [Abstract][Full Text] [Related]
8. Transplantation of Human Adipose Mesenchymal Stem Cells in Non-Immunosuppressed GRMD Dogs is a Safe Procedure.
Pelatti MV; Gomes JP; Vieira NM; Cangussu E; Landini V; Andrade T; Sartori M; Petrus L; Zatz M
Stem Cell Rev Rep; 2016 Aug; 12(4):448-53. PubMed ID: 27193781
[TBL] [Abstract][Full Text] [Related]
9. Human adipose-derived mesenchymal stromal cells injected systemically into GRMD dogs without immunosuppression are able to reach the host muscle and express human dystrophin.
Vieira NM; Valadares M; Zucconi E; Secco M; Bueno CR; Brandalise V; Assoni A; Gomes J; Landini V; Andrade T; Caetano HV; Vainzof M; Zatz M
Cell Transplant; 2012; 21(7):1407-17. PubMed ID: 23168016
[TBL] [Abstract][Full Text] [Related]
10. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.
Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM
Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404
[TBL] [Abstract][Full Text] [Related]
11. Dystrophin-deficient dogs with reduced myostatin have unequal muscle growth and greater joint contractures.
Kornegay JN; Bogan DJ; Bogan JR; Dow JL; Wang J; Fan Z; Liu N; Warsing LC; Grange RW; Ahn M; Balog-Alvarez CJ; Cotten SW; Willis MS; Brinkmeyer-Langford C; Zhu H; Palandra J; Morris CA; Styner MA; Wagner KR
Skelet Muscle; 2016; 6():14. PubMed ID: 27047655
[TBL] [Abstract][Full Text] [Related]
12. Muscle lesions associated with dystrophin deficiency in neonatal golden retriever puppies.
Nguyen F; Cherel Y; Guigand L; Goubault-Leroux I; Wyers M
J Comp Pathol; 2002; 126(2-3):100-8. PubMed ID: 11944998
[TBL] [Abstract][Full Text] [Related]
13. The golden retriever model of Duchenne muscular dystrophy.
Kornegay JN
Skelet Muscle; 2017 May; 7(1):9. PubMed ID: 28526070
[TBL] [Abstract][Full Text] [Related]
14. Skeletal Muscle Regenerative Potential of Human MuStem Cells following Transplantation into Injured Mice Muscle.
Lorant J; Saury C; Schleder C; Robriquet F; Lieubeau B; Négroni E; Leroux I; Chabrand L; Viau S; Babarit C; Ledevin M; Dubreil L; Hamel A; Magot A; Thorin C; Guevel L; Delorme B; Péréon Y; Butler-Browne G; Mouly V; Rouger K
Mol Ther; 2018 Feb; 26(2):618-633. PubMed ID: 29221805
[TBL] [Abstract][Full Text] [Related]
15. Alteration of cardiac progenitor cell potency in GRMD dogs.
Cassano M; Berardi E; Crippa S; Toelen J; Barthelemy I; Micheletti R; Chuah M; Vandendriessche T; Debyser Z; Blot S; Sampaolesi M
Cell Transplant; 2012; 21(9):1945-67. PubMed ID: 22513051
[TBL] [Abstract][Full Text] [Related]
16. Short-term treatment of golden retriever muscular dystrophy (GRMD) dogs with rAAVrh74.MHCK7.GALGT2 induces muscle glycosylation and utrophin expression but has no significant effect on muscle strength.
Martin PT; Zygmunt DA; Ashbrook A; Hamilton S; Packer D; Birch SM; Bettis AK; Balog-Alvarez CJ; Guo LJ; Nghiem PP; Kornegay JN
PLoS One; 2021; 16(3):e0248721. PubMed ID: 33770101
[TBL] [Abstract][Full Text] [Related]
17. Expiratory dysfunction in young dogs with golden retriever muscular dystrophy.
Hawkins EC; Bettis AK; Kornegay JN
Neuromuscul Disord; 2020 Nov; 30(11):930-937. PubMed ID: 33071066
[TBL] [Abstract][Full Text] [Related]
18. Glucose Metabolism as a Pre-clinical Biomarker for the Golden Retriever Model of Duchenne Muscular Dystrophy.
Schneider SM; Sridhar V; Bettis AK; Heath-Barnett H; Balog-Alvarez CJ; Guo LJ; Johnson R; Jaques S; Vitha S; Glowcwski AC; Kornegay JN; Nghiem PP
Mol Imaging Biol; 2018 Oct; 20(5):780-788. PubMed ID: 29508262
[TBL] [Abstract][Full Text] [Related]
19. Anatomical and mesoscopic characterization of the dystrophic diaphragm: An in vivo nuclear magnetic resonance imaging study in the Golden retriever muscular dystrophy dog.
Thibaud JL; Matot B; Barthélémy I; Fromes Y; Blot S; Carlier PG
Neuromuscul Disord; 2017 Apr; 27(4):315-325. PubMed ID: 28258941
[TBL] [Abstract][Full Text] [Related]
20. Use of the six-minute walk test to characterize golden retriever muscular dystrophy.
Acosta AR; Van Wie E; Stoughton WB; Bettis AK; Barnett HH; LaBrie NR; Balog-Alvarez CJ; Nghiem PP; Cummings KJ; Kornegay JN
Neuromuscul Disord; 2016 Dec; 26(12):865-872. PubMed ID: 27818009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
